{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:21:55Z","timestamp":1786990915634,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002657","name":"\u0130stanbul \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00dcB\u0130TAK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.imlet.2021.04.008","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T07:18:57Z","timestamp":1619162337000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease"],"prefix":"10.1016","volume":"235","author":[{"given":"Metin Yusuf","family":"Gelmez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esin Aktas","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulce","family":"Ozcit-G\u00fcrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goncagul","family":"Babuna-Kobaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Erdugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afet","family":"Akdag-Kose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnur","family":"Deniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2021.04.008_bib0001","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-4362.2003.01893.x","article-title":"Prevalence of Beh\u00e7et's disease in Istanbul, Turkey","author":"Azizlerli","year":"2003","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0002","doi-asserted-by":"crossref","DOI":"10.1097\/BOR.0000000000000003","article-title":"Genetics of Beh\u00e7et\u2019s disease: lessons learned from genomewide association studies","author":"G\u00fcl","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0003","series-title":"Pathogenesis of Beh\u00e7et's disease: Autoinflammatory features and Beyond","author":"G\u00fcl","year":"2015"},{"key":"10.1016\/j.imlet.2021.04.008_bib0004","doi-asserted-by":"crossref","DOI":"10.1038\/nrrheum.2015.147","article-title":"\u2019MHC-I-opathy\u2019-unified concept for spondyloarthritis and Beh\u00e7et disease","author":"McGonagle","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0005","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12436","article-title":"Origins and evolution of innate lymphoid cells: wardens of barrier immunity","author":"Neill","year":"2018","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.imlet.2021.04.008_bib0006","doi-asserted-by":"crossref","DOI":"10.1038\/ni.3459","article-title":"The evolution of innate lymphoid cells","author":"Vivier","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0007","series-title":"New Players in Tissue Homeostasis and Inflammatory Responses","article-title":"Innate lymphoid cells","author":"Zwirner","year":"2019"},{"key":"10.1016\/j.imlet.2021.04.008_bib0008","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20170494","article-title":"Dynamic balance between master transcription factors determines the fates and functions of CD4 T cell and innate lymphoid cell subsets","author":"Fang","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2021.04.008_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.09.011","article-title":"Innate lymphoid cells in allergic and nonallergic inflammation","author":"Morita","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0010","article-title":"Evidence of innate lymphoid cell redundancy in humans","author":"V\u00e9ly","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0011","doi-asserted-by":"crossref","DOI":"10.1586\/eci.09.27","article-title":"Natural killer cells: versatile roles in autoimmune and infectious diseases","author":"Aktas","year":"2009","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2008.08.007","article-title":"Relationship between CD107a expression and cytotoxic activity","author":"Aktas","year":"2009","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01999","article-title":"NK cell dysfunction and checkpoint immunotherapy","author":"Bi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0014","doi-asserted-by":"crossref","DOI":"10.1159\/000323963","article-title":"Modifications of the innate immune system in atopic dermatitis","author":"Maintz","year":"2011","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.imlet.2021.04.008_bib0015","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2002-09-2876","article-title":"CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity","author":"Fehniger","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2021.04.008_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8091492","article-title":"NK Cell Plasticity in Cancer","author":"Liu","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.imlet.2021.04.008_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/607921","article-title":"Diagnosis\/classification criteria for behcet's disease","author":"Davatchi","year":"2012","journal-title":"Patholog. Res. Int."},{"key":"10.1016\/j.imlet.2021.04.008_bib0018","article-title":"A. Cats, Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2021.04.008_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02179","article-title":"Imbalance of Circulating Innate Lymphoid Cell Subpopulations in Patients With Septic Shock","author":"Carvelli","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0020","series-title":"One Year in Review 2019: Beh\u00e7et's syndrome","author":"Hatemi","year":"2019"},{"key":"10.1016\/j.imlet.2021.04.008_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01067","article-title":"Beh\u00e7et\u2019s disease: an overview of etiopathogenesis","author":"Leccese","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0022","series-title":"Clin. Exp. Immunol","article-title":"Is Beh\u00e7et's disease a \u2018class 1-opathy\u2019? The role of HLA-B*51 in the pathogenesis of Beh\u00e7et's disease","author":"Giza","year":"2018"},{"key":"10.1016\/j.imlet.2021.04.008_bib0023","doi-asserted-by":"crossref","DOI":"10.1007\/s13317-016-0074-1","article-title":"Beh\u00e7et's disease physiopathology: a contemporary review","author":"Zeidan","year":"2016","journal-title":"Autoimmun. Highlights."},{"key":"10.1016\/j.imlet.2021.04.008_bib0024","doi-asserted-by":"crossref","DOI":"10.1007\/s00281-018-0688-7","article-title":"The roles for innate lymphoid cells in the human immune system","author":"Mazzurana","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2017.03.010","article-title":"Developmental options and functional plasticity of innate lymphoid cells","author":"Lim","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0026","series-title":"Innate Lymphoid cells: A New Paradigm in Immunology","author":"Eberl","year":"2015"},{"key":"10.1016\/j.imlet.2021.04.008_bib0027","series-title":"J. Clin. Med.","article-title":"Serum profiles of cytokines in Behcet's disease","author":"Sadeghi","year":"2017"},{"key":"10.1016\/j.imlet.2021.04.008_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.07.008","article-title":"Regulation of TH17 and regulatory T cells in patients with Behet disease","author":"Direskeneli","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6070074","article-title":"The role of Th17 cells in the pathogenesis of Behcet's disease","author":"Nanke","year":"2017","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.imlet.2021.04.008_bib0030","article-title":"ILC3 function as a double-edged sword in inflammatory bowel diseases","author":"Zeng","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.imlet.2021.04.008_bib0031","doi-asserted-by":"crossref","DOI":"10.1080\/08820139.2017.1288240","article-title":"Natural killer cell subsets and their functional activity in Beh\u00e7et's disease","author":"Cosan","year":"2017","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.imlet.2021.04.008_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02157","article-title":"Higher frequencies of lymphocytes expressing the natural killer group 2D receptor in patients with Beh\u00e7et disease","author":"Bonacini","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00134","article-title":"Beh\u00e7et\u2019s disease: do natural killer cells play a significant role?","author":"Petrushkin","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2016.12.001","article-title":"An elevated pro-inflammatory cytokines profile in Behcet\u2019s disease: a multiplex analysis","author":"Gholijani","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2021.04.008_bib0035","doi-asserted-by":"crossref","DOI":"10.1684\/ecn.2019.0421","article-title":"IL-17, IL-10, IL-6, and IFN-\u03b3 in Egyptian Beh\u00e7et's disease: correlation with clinical manifestations","author":"Talaat","year":"2019","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.imlet.2021.04.008_bib0036","doi-asserted-by":"crossref","DOI":"10.1080\/030097402320318387","article-title":"Cytokine profile in Beh\u00e7et\u2019s disease patients: relationship with disease activity","author":"Hamzaoui","year":"2002","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0037","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-3083.2011.02532.x","article-title":"Interleukin-4 gene polymorphisms confer Beh\u00e7et's disease in Turkish population","author":"Oral","year":"2011","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2004.07.005","article-title":"Abnormal expression of chemokine receptors in Beh\u00e7et\u2019s disease: relationship to intracellular Th1\/Th2 cytokines and to clinical manifestations","author":"Houman","year":"2004","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2021.04.008_bib0039","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keh195","article-title":"Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Beh\u00e7et\u2019s disease","author":"Koarada","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.imlet.2021.04.008_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00665","article-title":"Immunopathogenesis of Behcet's disease","author":"Tong","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0041","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.07-1390","article-title":"Upregulated IL-23 and IL-17 in Beh\u00e7et patients with active uveitis","author":"Chi","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.imlet.2021.04.008_bib0042","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-010-1531-2","article-title":"The role of IL-23\/IL-17 axis in the etiopathogenesis of Beh\u00e7et's disease","author":"Leng","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.imlet.2021.04.008_bib0043","series-title":"Serum IL-17A in Beh\u00e7et's disease","author":"Emiroglu","year":"2015"},{"key":"10.1016\/j.imlet.2021.04.008_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.154994","article-title":"Interleukin-17 mRNA expression and serum levels in Beh\u00e7et\u2019s disease","author":"Jadideslam","year":"2020","journal-title":"Cytokine"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247821000663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247821000663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:38:37Z","timestamp":1759045117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247821000663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":44,"alternative-id":["S0165247821000663"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2021.04.008","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2021.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}